317 results
Page 3 of 16
8-K
EX-99.1
9t5jm9
25 Feb 21
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:07pm
424B5
camh3u2 bm
16 Feb 21
Prospectus supplement for primary offering
4:49pm
424B5
sff5l7e4 azuvp
16 Feb 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-4.1
0x4xz1
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-10.1
4h28fouqx8o3i
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-10.2
aw07um
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-99.1
o3yq0r72t ovndf
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
8-K
EX-99.1
bf2hl26f9xt
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm
8-K
EX-10.2
ji9 2q8dcb7g6km
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
qwp1zmmqtt2im7pl3yi4
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-4.1
fj6rabj621
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B3
jh5876jvwz
29 Jun 20
Prospectus supplement
12:00am
424B5
o2lpaufahnsxo2
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
6ifikw
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-4.1
p69opmrian3jmd8dp
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-99.1
6hzd 8d3w
7 May 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results
4:09pm